Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000086150 | SCV000231676 | likely pathogenic | not provided | 2014-06-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000086150 | SCV000490429 | pathogenic | not provided | 2020-12-16 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect: while the protein possessing the R218C variant still localized to the plasma membrane, it failed to increase the Ca2+ dependent anion permeability in transfected cells (Milenkovic et al., 2011); Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed with an additional BEST1 variant in a patient with autosomal recessive bestrophinopathy in published literature, but it is not known whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (Luo et al., 2019); This variant is associated with the following publications: (PMID: 28687848, 29555955, 21878505, 23825107, 25489231, 29668979, 9700209, 30593719, 31570112, 31519547, 32239196, 29288639, 23213274, 29781975, 22633354) |
Fulgent Genetics, |
RCV000763263 | SCV000893901 | pathogenic | Autosomal recessive bestrophinopathy; Vitelliform macular dystrophy 2; Autosomal dominant vitreoretinochoroidopathy; Retinitis pigmentosa 50 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000086150 | SCV001205165 | pathogenic | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 218 of the BEST1 protein (p.Arg218Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant Best vitelliform macular dystrophy (PMID: 28687848, 29781975). This variant has been reported in individual(s) with autosomal recessive bestrophinopathy (PMID: 30593719); however, the role of the variant in this condition is currently unclear. ClinVar contains an entry for this variant (Variation ID: 99735). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BEST1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects BEST1 function (PMID: 21878505, 23825107). For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001073491 | SCV001239034 | pathogenic | Retinal dystrophy | 2019-03-31 | criteria provided, single submitter | clinical testing | |
Retina International | RCV000086150 | SCV000118294 | not provided | not provided | no assertion provided | not provided | ||
Department of Clinical Genetics, |
RCV000787543 | SCV000926517 | likely pathogenic | Vitelliform macular dystrophy 2 | 2018-04-01 | no assertion criteria provided | research |